Cc. Achkar et al., 4-OXORETINOL, A NEW NATURAL LIGAND AND TRANSACTIVATOR OF THE RETINOICACID RECEPTORS, Proceedings of the National Academy of Sciences of the United Statesof America, 93(10), 1996, pp. 4879-4884
All-trans-retinoic acid (at-RA) induces cell differentiation in a wide
variety of cell types, including F9 embryonic teratocarcinoma cells,
and can influence axial pattern formation during embryonic development
. We now identify a novel retinoid synthetic pathway in differentiatin
g F9 cells that results in the intracellular production of 4-oxoretino
l (4-oxo-ROL) from retinol (vitamin A). Approximately 10-15% of the to
tal retinol in the culture is metabolized to 4-hydroxyretinol and 4-ox
o-ROL by the at-RA-treated, differentiating F9 cells over an 18-hr per
iod, but no detectable metabolism of all-trans-retinol to at-RA, or 9-
cis-retinoic acid is observed in these cells. Remarkably, we show that
4-oxo-ROL can bind and activate transcription of the retinoic acid re
ceptors whereas all-trans-retinol shows neither activity. Low doses of
4-oxo-ROL (e.g., 10(-9) or 10(-10) M) can activate the retinoic acid
receptors even though, unlike at-RA, 4-oxo-ROL does not contain an aci
d moiety at the carbon 15 position. 4-oxo-ROL does not bind or transcr
iptionally activate the retinoid X receptors. Treatment of F9 cells wi
th 4-oxo-ROL induces differentiation without conversion to the acid an
d 4-oxo-ROL is active in causing axial truncation when administered to
Xenopus embryos at the blastula stage. Thus, 4-oxo-ROL is a natural,
biologically active retinoid that is present in differentiated F9 cell
s. Our data suggest that 4-oxo-ROL may be a novel signaling molecule a
nd regulator of cell differentiation.